Approvals/CIMA-AEMPS/OLMESARTAN/HIDROCLOROTIAZIDA TEVA 40 MG/12,5 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG

Approved

STANDARD

OLMESARTAN/HIDROCLOROTIAZIDA TEVA 40 MG/12,5 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG

Teva B.V.🇪🇸 Spanish Agency of Medicines and Medical Devices

Approval Id: c173d5a74b932ce1
Drug Cima Aemps Name: OLMESARTAN/HIDROCLOROTIAZIDA TEVA 40 MG/12,5 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG
Register Number: 86788
Holder Company Name: Teva B.V.
Marketing Company Name: Teva Pharma S.L.U.
Holder Company Detail Path: /organization/teva-pharma-b-v
Authorization Date: 2022-04-04
Dosage Form: COMPRIMIDO RECUBIERTO CON PELÍCULA
Dose: 40 mg/12,5 mg
Route Of Administration: VÍA ORAL
Prescription Type: Medicamento Sujeto A Prescripción Médica
Commercialized: Yes
Company Name: Teva B.V.
Company Detail Path: /organization/teva-pharma-b-v

OLMESARTAN MEDOXOMILO

40 mg

HIDROCLOROTIAZIDA

12,5 mg

Approved

Agency

CIMA-AEMPS

Country

🇪🇸

Approval Date

Apr 4, 2022

Approval ID

c173d5a74b932ce1

Type

Standard